A new collaboration will see Roswell Park Comprehensive Cancer Center partnering with the University of New Mexico (UNM), supported by a grant from the Bristol Myers Squibb Foundation, to address health disparities for the Pueblo Nations of New Mexico.

New research led by Roswell Park’s Brian Betts, MD, shows that adding a JAK inhibitor to standard treatment did not improve GvHD prevention for patients with hematologic cancers. Further research is warranted to determine whether this strategy might benefit patients who experience the chronic, more widely systemic form of GVHD.

New research led by Roswell Park experts in health behavior suggests that daily e-cigarette use may help some people to quit using combustible cigarettes.